Company overview
Illumina provides next-generation sequencing (NGS) and microarray technologies for life science research, translational genomics, and molecular diagnostics. Their sequencing by synthesis (SBS) platforms offer high-throughput, scalable solutions supporting applications in cancer research, reproductive health, microbiology, and more. These tools enable pharmaceutical R&D by accelerating genomic discoveries and improving workflows through integrated technology solutions.
Illumina is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services, Diagnostics & Testing partner serving United States & Americas. Core focus areas include illumina, next-generation sequencing, ngs platforms, genomic analysis, microarray technology.
Industry categories: CRO & Clinical Services, Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Illumina include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.illumina.com
- Categories
- CRO & Clinical Services, Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- illumina, next-generation sequencing, ngs platforms, genomic analysis, microarray technology
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What sequencing technologies does Illumina offer?
- Illumina offers next-generation sequencing (NGS) platforms using sequencing by synthesis (SBS) technology, providing ultra-high throughput, scalability, and support for single-read and paired-end libraries across benchtop and production-scale systems.
- What applications are supported by Illumina solutions?
- Illumina genomic solutions support diverse areas including reproductive and genetic health, cancer research, microbiology, translational genomics, and molecular diagnostics.
- What types of products does Illumina provide for pharma R&D?
- Illumina provides a broad range of sequencing platforms, microarray products, and integrated technology solutions designed for genomic analysis, research innovation, and workflow optimization in life sciences.
Related editorial coverage
- FDA Guidance on Next-Gen Sequencing for Gene Therapy Safety
- Stanford Patients Illuminate Health AI Adoption Challenges
- Next-Generation Sequencing MEA: Impact on Precision Oncology Treatment Selection
Explore lab tools and QA/QC resources for R&D teams.
